Consistent with the impaired anti-inflammatory activation of macrophages in vitro, our in vivo study showed that SLC37A2 deficiency in bone marrow lowers plasma IL-10 level and enhances atherosclerosis in WD-fed Ldlr−/− mice. Here, SLC37A2 is linked to atherosclerosis.